GlaxoSmithKline Market Cap 2006-2018 | GSK

Historical market capitalization for GlaxoSmithKline (GSK) over the last 10 years. The current market cap for GlaxoSmithKline (GSK) as of March 31, 2018 is $103.49B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.940B $38.892B
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $337.858B 16.72
Pfizer (PFE) United States $223.411B 13.75
Novartis AG (NVS) Switzerland $182.569B 15.82
Merck (MRK) United States $169.563B 15.15
AbbVie (ABBV) United States $153.340B 15.64
Novo Nordisk (NVO) Denmark $121.883B 20.19
Sanofi (SNY) France $105.164B 13.31
Eli Lilly (LLY) United States $97.374B 19.33
AstraZeneca (AZN) United Kingdom $94.122B 9.86
Bristol-Myers Squibb (BMY) United States $92.940B 18.28